Efficacy and safety of BI 1358894 in patients with borderline personality disorder: results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trial - Dwyer, Jennifer Holt; Schmahl, Christian; Makinodan, Manabu; Fineberg, Sarah K.; Sommer, Stephanie; Wruck, Jan; Jelaska, Ante; Adeniji, Abidemi; Goodman, Marianne (The journal of clinical psychiatry, 2025)
Gesehen am 23.07.2025